Skip to main content

Table 1 Association of LVD and other clinical and pathological parameters. P, t-test; P*, one-way ANOVA test; P**, Kruskal-Wallis test.

From: Clinical implications of increased lymph vessel density in the lymphatic metastasis of early-stage invasive cervical carcinoma: a clinical immunohistochemical method study

  

ILVD

PLVD

Variables

N

mean ± SD

P

mean ± SD

P

Catamenia

     

   Premenopause

29

7.83 ± 1.10

0.292

9.17 ± 0.80

0.358

   Postmenopause

12

7.42 ± 1.12

 

8.92 ± 0.79

 

Tumor size (cm)

     

   ≤ 4

26

7.58 ± 1.06

0.528

9.08 ± 0.84

0.831

   > 4

15

7.93 ± 1.22

 

9.13 ± 0.74

 

Stromal invasion

     

   ≤ 2/3

17

7.35 ± 0.86

0.089

8.94 ± 0.75

0.298

   > 2/3

24

7.96 ± 1.23

 

9.21 ± 0.83

 

FIGO stage

     

   Ia

7

6.86 ± 1.07

0.075*

8.57 ± 0.79

0.113*

   Ib

14

8.00 ± 1.24

 

9.07 ± 0.62

 

   IIa

20

7.80 ± 0.21

 

9.30 ± 0.86

 

Histological grade

     

   HG1

7

6.57 ± 0.96

0.009*

8.29 ± 0.76

0.012**

   HG2

13

7.85 ± 1.14

 

9.31 ± 0.63

 

   HG3

21

8.00 ± 0.95

 

9.24 ± 0.77

 

Lymph node metastasis

     

   Negative

26

7.38 ± 1.17

0.013

8.77 ± 0.65

0.0002

   Positive

15

8.27 ± 0.80

 

9.67 ± 0.72

 

LVI

     

   Negative

35

7.54 ± 1.09

0.021

8.94 ± 0.73

0.001

   Positive

6

8.67 ± 0.82

 

10.00 ± 0.63

 

Histological cell type

     

   SCC

37

7.62 ± 1.14

0.139

9.14 ± 0.79

0.367

   ADE

4

8.50 ± 0.58

 

8.75 ± 0.96

 
  1. Abbreviation: HG, histological grade; LVI, lymphatic vessel invasion; SCC, squamous cell carcinoma; ADE, adenocarcinoma.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us